Amgen To Slash Cholesterol Drug Price By 60 Percent After Years Of Struggling To Gain Foothold In Market

The new $5,850 a year price tag is still higher than cost-effectiveness watchdogs recommend, but it's a big drop from the original $14,000 a year. Sales never took off for the drug, in part because patients balked at the cost. Meanwhile, FDA Commissioner Scott Gottlieb sounds an alarm over pricey new cancer treatments.

from Kaiser Health News https://ift.tt/2D4ynSv